Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pollen-inspired multifunctional nanocarrier for porcine circovirus 2 vaccine delivery.

Journal of nanobiotechnology·2026

Same author

Antibody-Drug Conjugates (ADCs): A Review of Structural Design, Technological Evolution, and Future Perspectives.

Molecules (Basel, Switzerland)·2026

Same author

Role of microtubule affinity-regulating kinases in epilepsy: A novel therapeutic strategy.

British journal of pharmacology·2026

Same author

Dual and ultrasensitive electrochemical aptamer-based antibiotic biosensor via cascaded DNA assembly amplifications.

Talanta·2025

Same author

Bifunctional LYTAC Mediates Hepatocytes-Hepatic Stellate Cells Crosstalk by Regulating 5-HT<sub>2A</sub> Receptor Degradation and Antagonism to Synergistically Ameliorate Hepatic Fibrosis.

Journal of the American Chemical Society·2025

Same author

Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance.

Frontiers in immunology·2025

Search research articles

Related Experiment Video

Updated: Sep 12, 2025

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Biomaterials for biomarker imaging and detection.

Yan Wang¹, Xinyu Huang¹, Guiying Wu¹

¹College of Smart Agriculture, Yulin Normal University, Yulin 537000 Guangxi, China.

Journal of Advanced Research

|August 4, 2025

Summary

Advanced biomaterials like nanoparticles and quantum dots offer sensitive and specific detection of disease biomarkers. These innovations overcome traditional method limitations, paving the way for improved diagnostics and personalized medicine.

Keywords:

Biomarkers Biomaterials Clinical applications Detection Imaging

More Related Videos

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor

Published on: February 16, 2018

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Sep 12, 2025

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor

Published on: February 16, 2018

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Area of Science:

Biomaterials science
Medical imaging
Biotechnology

Background:

Accurate biomarker detection is crucial for disease diagnosis, prognosis, and personalized medicine.
Traditional detection methods (immunoassays, nucleic acid detection, mass spectrometry) lack sensitivity, specificity, and efficiency.
Novel technologies are urgently needed to enhance biomarker detection and imaging.

Purpose of the Study:

To provide a comprehensive overview of advanced biomaterials for biomarker imaging and detection.
To highlight the role of biomarkers in disease diagnosis and management.
To explore how new biomaterials overcome conventional detection method limitations.

Main Methods:

Review of physicochemical properties of biomaterials (nanoparticles, quantum dots, biopolymers).
Analysis of molecular recognition mechanisms integrated with advanced imaging technologies.
Examination of clinical translation challenges and future research directions.

Main Results:

Biomaterials enable highly sensitive, specific, and high-resolution biomarker detection.
Nanoparticle probes detect tumor markers at low concentrations; QD imaging provides cellular/tissue-level resolution.
Biomaterials show significant advantages in detecting biomarkers for cancer, cardiovascular, and neurodegenerative diseases.

Conclusions:

Biomaterial-based detection offers superior performance over traditional methods.
Further development is needed to accelerate clinical translation of these technologies.
Optimizing materials and imaging techniques is essential for widespread application.